[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341129-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341129-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pafah1b3-is-a-klf9-target-gene-that-promotes-proliferation-and-metastasis-in-pancreatic-cancer","PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer","","Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy driven by uncontrolled proliferation, invasion, and migration. Prior work indicated that KLF9 suppresses these malignant behaviors, but the mechanism remained unclear. This study identifies PAFAH1B3 as highly expressed in PDAC and shows that PAFAH1B3 overexpression promotes, while PAFAH1B3 downregulation inhibits, proliferation and invasion. KLF9 is inversely associated with PAFAH1B3, and KLF9 represses PAFAH1B3 transcription via direct promoter binding; PAFAH1B3 overexpression rescues KLF9-mediated inhibition. ",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pafah1b3-is-a-klf9-target-gene-that-promotes-proliferation-and-metastasis-in-pancreatic-cancer/341129/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pafah1b3-is-a-klf9-target-gene-that-promotes-proliferation-and-metastasis-in-pancreatic-cancer/341129.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does PAFAH1B3 play in pancreatic cancer cells?","Question",{"text":63,"@type":64},"PAFAH1B3 is highly expressed in pancreatic cancer tissues and cells. Overexpression promotes proliferation and invasion, while downregulation inhibits these processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is KLF9 related to PAFAH1B3 in PDAC?",{"text":68,"@type":64},"KLF9 expression is negatively correlated with PAFAH1B3 expression. Western blotting indicates that KLF9 negatively regulates PAFAH1B3 in pancreatic cancer cells and tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence shows KLF9 directly controls PAFAH1B3 transcription?",{"text":72,"@type":64},"Chromatin immunoprecipitation (ChIP) demonstrates that KLF9 binds the PAFAH1B3 promoter. Dual-luciferase reporter assays show that KLF9 inhibits PAFAH1B3 transcriptional activity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341129,1790115209,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer  \nCairong Dong1,3, Jinping Yao2,3, Zhipeng Wu1,3, Junwen Hu1, Liang Sun1, Zhengyi Wu1, Jinlong Yan1* & Xiangbao Yin1*  \nPancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. Uncontrolled cell proliferation, invasion and migration of pancreatic cancer cells are the fundamental causes of death in PDAC patients. Our previous studies showed that KLF9 inhibits the proliferation, invasion and migration of pancreatic cancer cells. However, the underlying mechanisms are not fully understood. In this study, we found that platelet-activating factor acetylhydrolase IB3 (PAFAH1B3) is highly expressed in pancreatic cancer tissues and cells. In vitro and in vivo studies showed that overexpression of PAFAH1B3 promoted the proliferation and invasion of pancreatic cancer cells, while downregulation of PAFAH1B3 inhibited these processes. We found that KLF9 expression is negatively correlated with PAFAH1B3 expression in pancreatic cancer tissues and cells. Western blotting revealed that KLF9 negatively regulates the expression of PAFAH1B3 in pancreatic cancer tissues and cells. Rescue experiments showed that overexpression of PAFAH1B3 could partially attenuate the suppression of pancreatic cancer cell proliferation, invasion and migration induced by KLF9 overexpression. Finally, chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays were carried out, and the results showed that KLF9 directly binds to the promoter of PAFAH1B3 and inhibits its transcriptional activity. In conclusion, our study indicated that KLF9 can inhibit the proliferation, invasion, migration and metastasis of pancreatic cancer cells by inhibiting PAFAH1B3 .  \nKeywords PAFAH1B3, KLF9, Proliferation and metastasis, PDAC  \nPancreatic ductal adenocarcinoma(PDAC) is the most common type of pancreatic cancer and accounts for approximately 85% of cases1.PDAC is the most lethal cancer and has a poor prognosis, and the overall 5-year survival rate is approximately 7%2.According to statistics, PDAC is currently the fourth most common cause of cancer-related death worldwide3 and is expected to become the second most lethal malignancy by 20304. Because most patients with PDAC are at an advanced stage at the time of presentation and have metastasized and lost the opportunity for surgery, only 15–20% of patients can be treated surgically5, and the vast majority of patients will eventually die from recurrence6. Thus, it is important to investigate the molecular mechanisms underlying PDAC development and identify new therapeutic targets for PDAC treatment.  \nThe platelet-activating factor acetylhydrolase 1B (PAFAH1B) complex is a heterotrimeric enzyme with a molecular weight of approximately 100 kDa. PAFAH1B3 is an important subunit α1 of PAFAH1B with a molecular weight of 29 kDa and is expressed by the PAFAH1B3 gene7. PAFAH1B3 has a wide range of physiological effects on the human body. Studies have shown that PAFAH1B3 plays an important role in human brain development8. Moreover, PAFAH1B3 affects the formation of spindles during meiosis and plays an important role in the formation and development ofoocytes and sperm cells9. In addition, PAFAH1B3 plays an important role in intracellular signal transduction, acute and chronic cellular stress responses, and intracellular protein transport10. Recent studies have shown that PAFAH1B3 also plays an important regulatory role in the occurrence and development of tumours. Metabolic remodelling is a common phenomenon in cancer cell metabolism and an important factor leading to poor cancer treatment response11. Lipid metabolism plays an important role in cancer progression12. PAFAH1B3 is an important metabolic enzyme that affects lipid metabolism in the body. Nilsson et al. reported that PAFAH1B3 is one of the 50 most commonly hig","cbCaiv5xHGMo7C77","https://ap.wps.com/l/cbCaiv5xHGMo7C77","pdf",7076729,16,"English","# Background\n## PDAC severity and unmet therapeutic needs\n# PAFAH1B3 and its biological relevance\n# KLF9-mediated regulation of PAFAH1B3\n## Expression correlation and protein regulation\n## Functional rescue experiments\n## Direct promoter binding and transcriptional repression","[{\"question\":\"What role does PAFAH1B3 play in pancreatic cancer cells?\",\"answer\":\"PAFAH1B3 is highly expressed in pancreatic cancer tissues and cells. Overexpression promotes proliferation and invasion, while downregulation inhibits these processes.\"},{\"question\":\"How is KLF9 related to PAFAH1B3 in PDAC?\",\"answer\":\"KLF9 expression is negatively correlated with PAFAH1B3 expression. Western blotting indicates that KLF9 negatively regulates PAFAH1B3 in pancreatic cancer cells and tissues.\"},{\"question\":\"What evidence shows KLF9 directly controls PAFAH1B3 transcription?\",\"answer\":\"Chromatin immunoprecipitation (ChIP) demonstrates that KLF9 binds the PAFAH1B3 promoter. Dual-luciferase reporter assays show that KLF9 inhibits PAFAH1B3 transcriptional activity.\"}]","PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer | PDF",1790040466,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/353ff02e2481cf3cca19ec1b87538fe5.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5afa829908c15749ad5ac6d2c3547e2c.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12aaa93dfdc840b24caa7db7ce7d5c42.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dca087bddf0b5e2b510d43cee83931eb.webp",980,1287]